# EDGAR Filing Document

**Accession Number:** 0001389545
**File Stem:** 0001437749-26-018547
**Filing Date:** 2026-5
**Character Count:** 10063
**Document Hash:** bd16612d4923b6e37f80d0bd5bdc41f8
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001437749-26-018547.hdr.sgml**: 20260527

**ACCESSION NUMBER**: 0001437749-26-018547

**CONFORMED SUBMISSION TYPE**: SCHEDULE 13D

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20260527

**DATE AS OF CHANGE**: 20260527

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Stablecoin Development Corp
- **CENTRAL INDEX KEY:** 0001389545
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 680454536
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-83670
- **FILM NUMBER:** 261026282

**BUSINESS ADDRESS:**
- **STREET 1:** 2000 POWELL STREET, SUITE 1150
- **CITY:** EMERYVILLE
- **STATE:** CA
- **ZIP:** 94608
- **BUSINESS PHONE:** (510) 899-8800

**MAIL ADDRESS:**
- **STREET 1:** 2000 POWELL STREET, SUITE 1150
- **CITY:** EMERYVILLE
- **STATE:** CA
- **ZIP:** 94608

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** NovaBay Pharmaceuticals, Inc.
- **DATE OF NAME CHANGE:** 20070209
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Sky Frontier Foundation
- **CENTRAL INDEX KEY:** 0002137030

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** E9
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D

**BUSINESS ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** SUITE 3119, 9 FORUM LN
- **STREET 2:** PO BOX 144
- **CITY:** GEORGE TOWN
- **NON US STATE TERRITORY:** GRAND CAYMAN
- **PROVINCE COUNTRY:** E9
- **ZIP:** KY1-9006
- **BUSINESS PHONE:** 00376388353

**MAIL ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** SUITE 3119, 9 FORUM LN
- **STREET 2:** PO BOX 144
- **CITY:** GEORGE TOWN
- **NON US STATE TERRITORY:** GRAND CAYMAN
- **PROVINCE COUNTRY:** E9
- **ZIP:** KY1-9006

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## SCHEDULE 13D

### Under the Securities Exchange Act of 1934

**Stablecoin Development Corp**

*(Name of Issuer)*

**Common Stock, $0.01 par value per share**

*(Title of Class of Securities)*

**—**

*(CUSIP Number)*

**David Garcia**<br>PO Box 144, 9 Forum Lane, Suite 3119<br>Camana Bay, George Town E9 KY 1-9006<br>345-749-9601

*(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)*

**05/17/2026**

*(Date of Event Which Requires Filing of this Statement)*

| **CUSIP No.** | **—** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Sky Frontier Foundation** | Name of reporting person<br>**Sky Frontier Foundation** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[ ] (a)<br>[x] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[ ] (a)<br>[x] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**WC** | Source of funds (See Instructions)<br>**WC** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**CAYMAN ISLANDS** | Citizenship or place of organization<br>**CAYMAN ISLANDS** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**0.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**3009502.00** | Aggregate amount beneficially owned by each reporting person<br>**3009502.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[x] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[x] | |
| 13 | Percent of class represented by amount in Row (11)<br>**9.9%** | Percent of class represented by amount in Row (11)<br>**9.9%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**OO** | Type of Reporting Person (See Instructions)<br>**OO** | |

---

**Comment for Reporting Person:** Non-U.S. Foundation

**Item 1. Security and Issuer**

**(a) Title of Class of Securities:**
Common Stock, $0.01 par value per share

**(b) Name of Issuer:**
Stablecoin Development Corp

**(c) Address of Issuer's Principal Executive Offices:**
2000 POWELL STREET, SUITE 1150, EMERYVILLE, CA, 94608

**Item 4. Purpose of Transaction**

The Reporting Person acquired a pre-funded warrant (the "Warrant") to purchase 100,000,000 shares of Common Stock (20,000,000 shares as adjusted for the Issuer's 1-for-5 reverse stock split effective February 20, 2026).  The Reporting Person did not acquire any shares of Common Stock in the transaction and does not currently hold any shares of Common Stock. The Warrant becomes exercisable in tranches as follows: 20% on July 16, 2026, an additional 30% on October 16, 2026 and the remaining 50% on January 16, 2027.

Exercise of the Warrant is subject to a beneficial ownership limitation (the "Beneficial Ownership Limitation") that prohibits the Reporting Person from exercising the Warrant to the extent that, after giving effect to the exercise, the Reporting Person, together with its affiliates and any other persons whose beneficial ownership would be aggregated with the Reporting Person's for purposes of Section 13(d) of the Securities Exchange Act of 1934, would beneficially own in excess of 9.99% of the outstanding Common Stock.  The Reporting Person may not increase the Beneficial Ownership Limitation above 9.99%.

In connection with the SPA, the Reporting Person, the Issuer, and the other purchasers also entered into an Investors' Rights Agreement (the "IRA").

The Reporting Person acquired the Warrant for long-term investment and to support the Issuer's adoption of, and integration with, the Sky protocol. The Reporting Person's investment is governance-focused and is not intended to result in a change of control of the Issuer or in any extraordinary corporate transaction involving the Issuer or any of its subsidiaries. Under the IRA, the Reporting Person has the right to nominate one director to the Issuer's board of directors for so long as the Reporting Person beneficially owns at least 5% of the outstanding Common Stock.

Also under the IRA, for a period of 24 months following January 16, 2026, the Reporting Person has the right to consent to any material amendment, modification, addition, revocation or change to the Issuer's Digital Asset Strategy, for so long as the Reporting Person continues to hold at least 50% of the Warrant or the Common Stock originally acquired by it.

Except as set forth in this statement, the Reporting Person has no present plans or proposals that relate to or would result in any of the actions specified in clauses (a) through (j) of Item 4 of Schedule 13D. The Reporting Person reserves the right to change its plans or intentions and to take any action permitted by applicable law with respect to its investment in the Issuer.

**Item 5. Interest in Securities of the Issuer**

**(a)**
As of May 17, 2026, the Reporting Person may be deemed to beneficially own 3,009,502 shares of Common Stock, representing approximately 9.99% of the outstanding Common Stock.  The percentage is calculated based on 27,115,646 shares of Common Stock outstanding, plus the 3,009,502 shares issuable to the Reporting Person upon exercise of the Warrant within 60 days, subject to the Beneficial Ownership Limitation. The Reporting Person disclaims beneficial ownership of any shares of Common Stock issuable upon exercise of the Warrant in excess of the Beneficial Ownership Limitation.

**(b)**
Upon and following exercise of the Warrant, the Reporting Person will have sole voting power and sole dispositive power with respect to the 3,009,502 shares issuable upon such exercise. The Reporting Person does not currently have voting or dispositive power over any shares of Common Stock.

**(c)**
Except for the acquisition of the Warrant described in Item 4, the Reporting Person has not effected any transaction in the Common Stock during the past 60 days.

**Item 6. Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer.**

The information set forth in Items 3, 4, and 5 of this statement is incorporated by reference into this Item 6. The SPA, the Warrant, the IRA and related documents entered into in connection therewith are the only contracts, arrangements, understandings or relationships to which the Reporting Person is a party with respect to securities of the Issuer. The descriptions of the SPA, Warrant and IRA above do not purport to be complete and are qualified in their entirety by reference to the SPA, Warrant and IRA, which are filed as exhibits to this Schedule 13D, and are incorporated by reference herein.

Except as described in this statement, the Reporting Person is not a party to any contract, arrangement, understanding, or relationship (legal or otherwise) with any other person with respect to any securities of the Issuer, including with respect to the transfer or voting of any of the securities, finder's fees, joint ventures, loan or option arrangements, puts or calls, guarantees of profits, division of profits or loss, or the giving or withholding of proxies.

### SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Sky Frontier Foundation

**Signature:** /s/ David Garcia

**Name/Title:** David Garcia, Director

**Date:** 05/27/2026